- Novo says Ozempic to be eligible for US price negotiations in less than a year Yahoo! Voices
- Novo CEO Faces Sanders Over GLP-1 Drug Prices. All of Pharma Should Tune In. Barron’s
- $50 Billion in Sales Make Ozempic and Wegovy Prices Tougher to Justify Bloomberg
- Novo Nordisk faces US congressional…
[ad_2]
Source link